全球核子醫學掃描術診斷設備市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

預計核子醫學掃描術診斷設備市場將從 2025 年的 39.3 億美元成長到 2034 年的 69.1 億美元，2026 年至 2034 年的複合年成長率為 6.48%。

由於醫療技術的進步和醫療需求的不斷成長，核子醫學掃描術診斷設備市場預計將迎來顯著成長，這主要得益於對精準診斷工具的需求。核子醫學影像利用放射性物質對器官和組織的功能進行視覺化，正日益成為各種疾病診斷和治療中不可或缺的一部分。隨著全球人口老化和慢性病的盛行率上升，對核子醫學掃描術診斷設備的需求預計將持續成長，從而推動市場擴張。

技術創新在提升核子醫學掃描術診斷設備的功能方面發揮著至關重要的作用。正子斷層掃描（PET）和單光子發射斷層掃描（SPECT）等影像技術的進步提高了診斷影像的準確性和解析度。這些進步使醫療專業人員能夠更早發現疾病，從而改善患者的治療效果。此外，人工智慧（AI）和機器學習在核子醫學掃描術診斷中的應用簡化了影像分析和解讀流程，進一步提高了診斷效率。隨著這些技術的不斷發展，核子醫學掃描術診斷設備市場有望吸引醫療機構和製造商的大量投資。

此外，對個人化醫療和標靶治療日益成長的關注也推動了核子醫學掃描術診斷設備市場的成長。隨著醫療保健轉向更個人化的治療方案，對精準診斷工具的需求變得愈發重要。核子醫學掃描術診斷設備能夠提供關於患者俱體病情的寶貴資訊，並有助於制定個人化的治療方案。此外，對早期檢測和預防醫學的日益重視也促進了核醫學影像技術的應用。隨著市場的不斷發展，核醫學影像與其他診斷方法的融合有望創造新的機遇，並進一步加速這個充滿活力的領域的成長。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

第4章 全球核子醫學掃描術診斷設備市場：依產品類型分類

• 市場分析、洞察與預測
• PET設備
• SPECT設備
• 平面成像設備

第5章 全球核子醫學掃描術診斷設備市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 心臟病學
• 神經病學
• 其他領域（腎臟科、免疫學等）

第6章 全球核子醫學掃描術診斷設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 影像中心
• 學術研究機構
• 其他（診所、合約研究組織等）

第7章 全球核子醫學掃描術診斷設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • United Imaging Healthcare Co
  • MR Solutions
  • Cubresa Inc
  • Neusoft Medical Systems Co. Ltd
  • Mediso Ltd
  • MIE GmbH
  • Others

The Nuclear Imaging Devices Market size is expected to reach USD 6.91 Billion in 2034 from USD 3.93 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.

The Nuclear Imaging Devices Market is anticipated to witness significant growth as advancements in medical technology and increasing healthcare demands drive the need for accurate diagnostic tools. Nuclear imaging, which utilizes radioactive materials to visualize the functioning of organs and tissues, is becoming an essential component in the diagnosis and management of various medical conditions. As the global population ages and the prevalence of chronic diseases rises, the demand for nuclear imaging devices is expected to increase, propelling market expansion.

Technological innovations are playing a crucial role in enhancing the capabilities of nuclear imaging devices. Developments in imaging techniques, such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), are improving the accuracy and resolution of diagnostic images. These advancements enable healthcare professionals to detect diseases at earlier stages, leading to better patient outcomes. Additionally, the integration of artificial intelligence and machine learning in nuclear imaging is streamlining image analysis and interpretation, further enhancing the efficiency of diagnostic processes. As these technologies continue to evolve, the nuclear imaging devices market is likely to attract significant investments from healthcare providers and manufacturers.

Moreover, the increasing focus on personalized medicine and targeted therapies is influencing the growth of the nuclear imaging devices market. As healthcare shifts towards more individualized treatment approaches, the need for precise diagnostic tools becomes paramount. Nuclear imaging devices provide valuable insights into patient-specific conditions, allowing for tailored treatment plans. Furthermore, the growing emphasis on early detection and preventive healthcare is driving the adoption of nuclear imaging technologies. As the market evolves, the integration of nuclear imaging with other diagnostic modalities is expected to create new opportunities, further fueling growth in this dynamic sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• PET Devices
• SPECT Devices
• Planar Imaging Devices

By Application

• Oncology
• Cardiology
• Neurology
• Others (Nephrology, Immunology, etc.)

By End-User

• Hospitals
• Imaging Centers
• Academic And Research Centers
• Others (Clinics, CROs, Etc.)

COMPANIES PROFILED

• Koninklijke Philips NV, GE HealthCare Technologies Inc, Siemens Healthineers AG, Canon Medical Systems Corporation, Shimadzu Corporation, United Imaging Healthcare Co, MR Solutions, Cubresa Inc, Neusoft Medical Systems Co Ltd, Mediso Ltd, MIE GmbH, Others

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. PET Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. SPECT Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Planar Imaging Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others (Nephrology, Immunology, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others (Clinics, CROs, Etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUCLEAR IMAGING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NUCLEAR IMAGING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Koninklijke Philips N.V
  • 9.2.2 GE HealthCare Technologies Inc
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Canon Medical Systems Corporation
  • 9.2.5 Shimadzu Corporation
  • 9.2.6 United Imaging Healthcare Co
  • 9.2.7 MR Solutions
  • 9.2.8 Cubresa Inc
  • 9.2.9 Neusoft Medical Systems Co. Ltd
  • 9.2.10 Mediso Ltd
  • 9.2.11 MIE GmbH
  • 9.2.12 Others